Vimarsana
Biggest News Aggregation in the World

Page 35 - Accessed March News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Accessed March. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Accessed March Today - Breaking & Trending Today

Dupilumab Under Review for Chronic Spontaneous Urticaria - Vimarsana News

Dupilumab Under Review for Chronic Spontaneous Urticaria

The FDA has accepted for review the sBLA for dupilumab for the treatment of patients with chronic spontaneous urticaria.

Source: empr.com
FDA Approves Autoinjector Presentation of Pegfilgrastim Biosimilar Udenyca - Vimarsana News

FDA Approves Autoinjector Presentation of Pegfilgrastim Biosimilar Udenyca

The FDA has approved a new single-dose prefilled autoinjector of Udenyca (pegfilgrastim-cbqv), a biosimilar to Neulasta.

Abbott's Modified CGM Sensors Cleared for Integration With AID Systems - Vimarsana News

Abbott's Modified CGM Sensors Cleared for Integration With AID Systems

The FDA has cleared Abbott's FreeStyle Libre 2 and FreeStyle Libre 3 CGM system sensors for integration with automated insulin delivery systems.

Source: empr.com
FDA Expands Breast Cancer Indications for Verzenio - Vimarsana News

FDA Expands Breast Cancer Indications for Verzenio

The FDA has expanded the approval of Verzenio (abemaciclib) plus endocrine therapy removing the Ki-67 score requirement for patient selection.

Source: empr.com
FDA Expands Breast Cancer Indications for Verzenio - Vimarsana News

FDA Expands Breast Cancer Indications for Verzenio

The FDA has expanded the approval of Verzenio (abemaciclib) plus endocrine therapy, removing the Ki-67 score requirement for selection.